As a former chief fellow in Hematology and Medical Oncology at Oregon Health and Science University in Portland, Oregon, Natasha Tiffany, MD is a now a physician in private practice at Oregon Oncology Specialists. She holds several notable board certifications and license status, including medical oncology, hematology, internal medicine, and an Oregon medical license. A career oncologist, Natasha Tiffany, MD always keeps up with new trends in managing cancer, especially personalized medicine (PM).
Also known as precision medicine, PM is a relatively new method to treat and prevent tumors. It considers the variability of genes and the differences in morbidity and lifestyle of people with cancer. Personalization allows researchers and drug manufacturers to customize the approach to the tumor and the environment, thus offering better patient care. People with cancer are often in pain. Increasing quality of life forms a primary facet of care for those on anti-cancer treatment, such as chemotherapy, and those at the end-of-life stage where the treatment does not work anymore. PM in oncology is used to optimize anti-cancer therapy and is applicable in offering supportive care for patients with malignancies. An example is the use of targeted therapy such as Osimertinib (Tagrisso) in lung cancer with EGFR mutations. Patients with EGFR mutated lung cancer can benefit from targeted therapy for years, delaying the need for chemotherapy. Chemotherapy is harder to tolerate and can cause nausea, vomiting, and hair loss. Personalized medicine significantly reduces these issues.
0 Comments
Leave a Reply. |
AuthorNatasha Tiffany, MD, is a physician, educator, and research scientist currently working in Oregon. A Partner and Physician in a private practice located in the state’s capital city of Salem, Dr. Tiffany teaches at her alma mater, Oregon Health & Science University, where she is an Affiliate Assistant Professor in the Hematology and Medical Oncology Division. Archives
October 2019
Categories
All
|